siRNA, Anti-SLC13A1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT21269WQ-2OMe)

The product SIRGT21269WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC13A1 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC13A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001324400.1; NM_022444.3
Alternative Names NAS1; NaSi-1
Related Diseases Atelosteogenesis
Purification HPLC
Target Gene
Gene ID 6561
Uniprot ID Q9BZW2
Sub Cat Target Species Modification Scale  
SIRGT22269WQ-2F SLC13A1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT23269WQ-2MOE SLC13A1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT24269WQ-LNA SLC13A1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT21269WQ-RB SLC13A1 Human Ribo-modified Inquiry
SIRGT22269WQ-BB SLC13A1 Human Backbone-modified Inquiry

Related Products